Jazz Pharmaceuticals plc Depreciation
Jazz Pharmaceuticals plc (JAZZ) reported Depreciation of $18.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-03
- Jazz Pharmaceuticals plc depreciation for the quarter ending 2026-06-30 was $9.10M, a 23.53% decline year-over-year.
- Jazz Pharmaceuticals plc depreciation for the quarter ending 2026-03-31 was $9.10M, a 12.50% decline year-over-year.
- Jazz Pharmaceuticals plc depreciation for the quarter ending 2025-12-31 was $9.43M, a 0.91% decline year-over-year.
- Jazz Pharmaceuticals plc depreciation for the quarter ending 2025-09-30 was $9.91M, a 27.45% increase year-over-year.
- Jazz Pharmaceuticals plc depreciation for fiscal 2025 was $41.64M, a 27.12% increase from fiscal 2024.
- Jazz Pharmaceuticals plc depreciation for fiscal 2024 was $32.75M, a 7.70% increase from fiscal 2023.
- Jazz Pharmaceuticals plc depreciation for fiscal 2023 was $30.41M, a 0.36% increase from fiscal 2022.
- Jazz Pharmaceuticals plc depreciation for fiscal 2022 was $30.30M, a 13.43% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $18.20M 10-Q · filed 2026-08-03 | $27.63M derived: sum of 3 quarters · filed 2026-08-03 | $37.54M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $9.10M 10-Q · filed 2026-05-05 | $18.53M derived: sum of 2 quarters · filed 2026-05-05 | $28.44M derived: sum of 3 quarters · filed 2026-05-05 | $40.34M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $9.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $19.34M derived: sum of 2 quarters · filed 2026-02-24 | $31.24M derived: sum of 3 quarters · filed 2026-08-03 | $41.64M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $9.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $21.81M derived: sum of 2 quarters · filed 2026-08-03 | $32.21M 10-Q · filed 2025-11-05 | $41.72M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $11.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $22.30M 10-Q · filed 2026-08-03 | $22.33M 10-Q · filed 2025-08-06 | $31.81M derived: sum of 3 quarters · filed 2026-08-03 | $39.59M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $10.40M 10-Q · filed 2026-05-05 | $10.43M 10-Q · filed 2025-05-07 | $19.91M derived: sum of 2 quarters · filed 2026-05-05 | $27.69M derived: sum of 3 quarters · filed 2026-05-05 | $35.50M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $9.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $17.29M derived: sum of 2 quarters · filed 2026-02-24 | $25.10M derived: sum of 3 quarters · filed 2026-02-24 | $32.75M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $7.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $15.59M derived: sum of 2 quarters · filed 2025-11-05 | $23.24M 10-Q · filed 2025-11-05 | $30.89M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | $7.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $15.46M 10-Q · filed 2025-08-06 | $23.11M derived: sum of 3 quarters · filed 2026-02-24 | $30.79M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $7.65M 10-Q · filed 2025-05-07 | $15.30M derived: sum of 2 quarters · filed 2026-02-24 | $22.98M derived: sum of 3 quarters · filed 2026-02-24 | $30.49M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | $7.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $15.32M derived: sum of 2 quarters · filed 2026-02-24 | $22.84M derived: sum of 3 quarters · filed 2026-02-24 | $30.41M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | $7.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $15.19M derived: sum of 2 quarters · filed 2024-11-07 | $22.76M 10-Q · filed 2024-11-07 | $30.11M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | $7.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $15.09M 10-Q · filed 2024-08-01 | $22.43M derived: sum of 3 quarters · filed 2025-02-26 | $30.03M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | $7.57M 10-Q · filed 2024-05-02 | $14.92M derived: sum of 2 quarters · filed 2025-02-26 | $22.51M derived: sum of 3 quarters · filed 2025-02-26 | $30.26M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | $7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $14.94M derived: sum of 2 quarters · filed 2025-02-26 | $22.68M derived: sum of 3 quarters · filed 2025-02-26 | $30.30M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $7.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $15.34M derived: sum of 2 quarters · filed 2023-11-08 | $22.96M 10-Q · filed 2023-11-08 | $30.29M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $7.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $15.36M 10-Q · filed 2023-08-09 | $22.69M derived: sum of 3 quarters · filed 2024-02-28 | $30.46M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $7.62M 10-Q · filed 2023-05-10 | $14.94M derived: sum of 2 quarters · filed 2024-02-28 | $22.72M derived: sum of 3 quarters · filed 2024-02-28 | $29.55M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $7.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $15.10M derived: sum of 2 quarters · filed 2024-02-28 | $21.93M derived: sum of 3 quarters · filed 2024-02-28 | $26.71M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $7.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $14.61M derived: sum of 2 quarters · filed 2022-11-09 | $19.39M 10-Q · filed 2022-11-09 | $23.98M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $6.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $11.61M 10-Q · filed 2022-08-03 | $16.21M derived: sum of 3 quarters · filed 2023-03-01 | $21.02M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $4.78M 10-Q · filed 2022-05-04 | $9.38M derived: sum of 2 quarters · filed 2023-03-01 | $14.19M derived: sum of 3 quarters · filed 2023-03-01 | $18.93M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $9.41M derived: sum of 2 quarters · filed 2023-03-01 | $14.15M derived: sum of 3 quarters · filed 2023-03-01 | $18.67M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $4.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $9.55M derived: sum of 2 quarters · filed 2021-11-09 | $14.08M 10-Q · filed 2021-11-09 | $18.53M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $4.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $9.27M 10-Q · filed 2021-08-03 | $13.72M derived: sum of 3 quarters · filed 2022-03-01 | $17.71M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $4.53M 10-Q · filed 2021-05-04 | $8.98M derived: sum of 2 quarters · filed 2022-03-01 | $12.97M derived: sum of 3 quarters · filed 2022-03-01 | $16.33M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $4.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $8.45M derived: sum of 2 quarters · filed 2022-03-01 | $11.80M derived: sum of 3 quarters · filed 2022-03-01 | $15.34M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $3.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $7.35M derived: sum of 2 quarters · filed 2020-11-02 | $10.88M 10-Q · filed 2020-11-02 | $14.76M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-06-30 | $3.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $6.89M 10-Q · filed 2020-08-04 | $10.76M derived: sum of 3 quarters · filed 2021-02-23 | $14.67M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-03-31 | $3.54M 10-Q · filed 2020-05-05 | $7.41M derived: sum of 2 quarters · filed 2021-02-23 | $11.31M derived: sum of 3 quarters · filed 2021-02-23 | $15.05M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2018-12-31 | $3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $7.78M derived: sum of 2 quarters · filed 2021-02-23 | $11.51M derived: sum of 3 quarters · filed 2021-02-23 | $15.23M 10-K · filed 2021-02-23 | ||
| 2018-09-30 | $3.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $7.64M derived: sum of 2 quarters · filed 2019-11-05 | $11.36M 10-Q · filed 2019-11-05 | $15.16M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | $3.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $7.46M 10-Q · filed 2019-08-06 | $11.26M derived: sum of 3 quarters · filed 2020-02-25 | $14.32M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $3.72M 10-Q · filed 2019-05-07 | $7.52M derived: sum of 2 quarters · filed 2020-02-25 | $10.59M derived: sum of 3 quarters · filed 2020-02-25 | $13.68M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $6.87M derived: sum of 2 quarters · filed 2020-02-25 | $9.96M derived: sum of 3 quarters · filed 2020-02-25 | $13.09M 10-K · filed 2020-02-25 | ||
| 2017-09-30 | $3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $6.16M derived: sum of 2 quarters · filed 2018-11-06 | $9.29M 10-Q · filed 2018-11-06 | $12.91M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | $3.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $6.22M 10-Q · filed 2018-08-07 | $9.84M derived: sum of 3 quarters · filed 2019-02-26 | $12.96M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | $3.13M 10-Q · filed 2018-05-08 | $6.75M derived: sum of 2 quarters · filed 2019-02-26 | $9.87M derived: sum of 3 quarters · filed 2019-02-26 | $12.39M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2016-12-31 | $3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $6.74M derived: sum of 2 quarters · filed 2019-02-26 | $9.26M derived: sum of 3 quarters · filed 2019-02-26 | $11.79M 10-K · filed 2019-02-26 | ||
| 2016-09-30 | $3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $5.64M derived: sum of 2 quarters · filed 2017-11-07 | $8.16M 10-Q · filed 2017-11-07 | $10.92M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $5.04M 10-Q · filed 2017-08-08 | $7.79M derived: sum of 3 quarters · filed 2018-02-27 | $10.34M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $2.53M 10-Q · filed 2017-05-09 | $5.28M derived: sum of 2 quarters · filed 2018-02-27 | $7.83M derived: sum of 3 quarters · filed 2018-02-27 | $10.19M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $5.30M derived: sum of 2 quarters · filed 2018-02-27 | $7.66M derived: sum of 3 quarters · filed 2018-02-27 | $9.89M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $4.91M derived: sum of 2 quarters · filed 2016-11-08 | $7.14M 10-Q · filed 2016-11-08 | $9.20M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.59M 10-Q · filed 2016-08-09 | $6.66M derived: sum of 3 quarters · filed 2017-02-28 | $8.52M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $2.23M 10-Q · filed 2016-05-10 | $4.29M derived: sum of 2 quarters · filed 2017-02-28 | $6.16M derived: sum of 3 quarters · filed 2017-02-28 | $8.02M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $3.93M derived: sum of 2 quarters · filed 2017-02-28 | $5.79M derived: sum of 3 quarters · filed 2017-02-28 | $7.10M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $3.73M derived: sum of 2 quarters · filed 2015-11-09 | $5.04M 10-Q · filed 2015-11-09 | $6.02M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | $1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $3.17M 10-Q · filed 2015-08-05 | $4.15M derived: sum of 3 quarters · filed 2016-02-23 | $5.05M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | $1.31M 10-Q · filed 2015-05-07 | $2.29M derived: sum of 2 quarters · filed 2016-02-23 | $3.19M derived: sum of 3 quarters · filed 2016-02-23 | $3.78M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2013-12-31 | $983.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $1.88M derived: sum of 2 quarters · filed 2016-02-23 | $2.47M derived: sum of 3 quarters · filed 2016-02-23 | $3.05M 10-K · filed 2016-02-23 | ||
| 2013-09-30 | $895.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $1.49M derived: sum of 2 quarters · filed 2014-11-04 | $2.06M 10-Q · filed 2014-11-04 | $2.58M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $595.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $1.17M 10-Q · filed 2014-08-05 | $1.69M derived: sum of 3 quarters · filed 2015-02-24 | $2.06M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $575.00K 10-Q · filed 2014-05-08 | $1.09M derived: sum of 2 quarters · filed 2015-02-24 | $1.47M derived: sum of 3 quarters · filed 2015-02-24 | $1.70M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2012-12-31 | $518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $892.00K derived: sum of 2 quarters · filed 2015-02-24 | $1.12M derived: sum of 3 quarters · filed 2015-02-24 | $1.31M 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $374.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $603.00K derived: sum of 2 quarters · filed 2013-11-05 | $789.00K 10-Q · filed 2013-11-05 | $900.00K derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-06-30 | $229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $415.00K 10-Q · filed 2013-08-06 | $526.00K derived: sum of 3 quarters · filed 2014-02-25 | $605.00K derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-03-31 | $186.00K 10-Q · filed 2013-05-07 | $297.00K derived: sum of 2 quarters · filed 2014-02-25 | $376.00K derived: sum of 3 quarters · filed 2014-02-25 | $461.00K derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2011-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $190.00K derived: sum of 2 quarters · filed 2014-02-25 | $275.00K derived: sum of 3 quarters · filed 2014-02-25 | $379.00K 10-K · filed 2014-02-25 | ||
| 2011-09-30 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $164.00K derived: sum of 2 quarters · filed 2012-11-09 | $268.00K 10-Q · filed 2012-11-09 | $441.00K derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $189.00K 10-Q · filed 2012-08-07 | $362.00K derived: sum of 3 quarters · filed 2013-02-26 | $550.00K derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-03-31 | $104.00K 10-Q · filed 2012-05-08 | $277.00K derived: sum of 2 quarters · filed 2013-02-26 | $465.00K derived: sum of 3 quarters · filed 2013-02-26 | |||
| 2010-12-31 | $173.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $361.00K derived: sum of 2 quarters · filed 2013-02-26 | $886.00K 10-K · filed 2013-02-26 | |||
| 2010-09-30 | $188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $713.00K 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $525.00K 10-Q · filed 2011-08-03 | |||||
| 2009-12-31 | $1.43M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |